Originally created to help people with diabetes regulate insulin levels, the injectable is now one of the foremost weight management medications available
But we've taken it to the next level
The American Diabetes Association (ADA) also recommends GLP1RAs therapy for weight loss & lesser risk of hypoglycemia in type 2 diabetes mellitus patients
With the right guidance, you can keep reaching your health goals and feel good about it
The sum of evidence suggests that, when detected, the use of GLP-1/GIP agonists is associated with the development of mild DR or a slight worsening of existing retinopathy
Document your progress at weeks 4, 8, and 12 to have clear data for your healthcare provider when deciding whether to continue, adjust, or pause treatment